A Phase 1, Open-Label, Single-Dose, Parallel Group Study to Compare the Pharmacokinetics of PF-07081532 in Adult Participants with Varying Degrees of Hepatic Impairment Relative to Participants without Hepatic Impairment

A Study on How Lotiglipron is Processed in Adults With Liver Impairment Compared to Adults Without Liver Impairment

Category & Conditions: Diabetes and Metabolic Disorders

Medicine: PF-07081532

ClinicalTrials.gov Identifier (NCT): NCT05478603

Protocol ID: C3991009

Print Download

Open Plain Language Summary Result: Click here